Boston Scientific (BSX) Research & Development (2016 - 2025)
Boston Scientific (BSX) has disclosed Research & Development for 17 consecutive years, with $569.0 million as the latest value for Q4 2025.
- Quarterly Research & Development rose 23.97% to $569.0 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $2.1 billion through Dec 2025, up 27.06% year-over-year, with the annual reading at $2.1 billion for FY2025, 27.06% up from the prior year.
- Research & Development hit $569.0 million in Q4 2025 for Boston Scientific, up from $514.0 million in the prior quarter.
- In the past five years, Research & Development ranged from a high of $569.0 million in Q4 2025 to a low of $276.0 million in Q1 2021.
- Historically, Research & Development has averaged $380.4 million across 5 years, with a median of $357.5 million in 2023.
- Biggest five-year swings in Research & Development: dropped 8.0% in 2021 and later surged 37.34% in 2025.
- Year by year, Research & Development stood at $320.0 million in 2021, then increased by 3.12% to $330.0 million in 2022, then rose by 10.0% to $363.0 million in 2023, then grew by 26.45% to $459.0 million in 2024, then grew by 23.97% to $569.0 million in 2025.
- Business Quant data shows Research & Development for BSX at $569.0 million in Q4 2025, $514.0 million in Q3 2025, and $526.0 million in Q2 2025.